But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...

Indian-origin scientist Vinay Prasad resigned as the FDA's vaccine and gene therapy chief in just three months after backlash ...

PTC Therapeutics faces pivotal FDA decisions for approvals that could potentially transform their long-term revenues. Click ...

The Trump administration is reportedly considering a major restructuring of the FDA’s biologics division, potentially ...